IE45260B1 - Pelletised or granular medicament formulation - Google Patents

Pelletised or granular medicament formulation

Info

Publication number
IE45260B1
IE45260B1 IE14/77A IE1477A IE45260B1 IE 45260 B1 IE45260 B1 IE 45260B1 IE 14/77 A IE14/77 A IE 14/77A IE 1477 A IE1477 A IE 1477A IE 45260 B1 IE45260 B1 IE 45260B1
Authority
IE
Ireland
Prior art keywords
medicament
particles
microns
granules
soft
Prior art date
Application number
IE14/77A
Other languages
English (en)
Other versions
IE45260L (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB260676A external-priority patent/GB1569611A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to IE1844/80A priority Critical patent/IE45262B1/en
Priority to IE1843/80A priority patent/IE45261B1/en
Publication of IE45260L publication Critical patent/IE45260L/xx
Publication of IE45260B1 publication Critical patent/IE45260B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE14/77A 1976-01-23 1977-01-05 Pelletised or granular medicament formulation IE45260B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IE1844/80A IE45262B1 (en) 1976-01-23 1977-01-05 Disodium cromoglycate in a novel from
IE1843/80A IE45261B1 (en) 1976-01-23 1977-01-05 Disodium cromoglycate pellets or granules

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB260676A GB1569611A (en) 1976-01-23 1976-01-23 Pelletised or granular medicament formulation
GB260876 1976-01-23

Publications (2)

Publication Number Publication Date
IE45260L IE45260L (en) 1977-07-23
IE45260B1 true IE45260B1 (en) 1982-07-28

Family

ID=26237614

Family Applications (1)

Application Number Title Priority Date Filing Date
IE14/77A IE45260B1 (en) 1976-01-23 1977-01-05 Pelletised or granular medicament formulation

Country Status (12)

Country Link
JP (1) JPS5294413A (enrdf_load_stackoverflow)
AU (1) AU506878B2 (enrdf_load_stackoverflow)
CA (1) CA1116516A (enrdf_load_stackoverflow)
DK (1) DK27177A (enrdf_load_stackoverflow)
ES (1) ES455273A1 (enrdf_load_stackoverflow)
FI (1) FI67663C (enrdf_load_stackoverflow)
FR (1) FR2361104A2 (enrdf_load_stackoverflow)
IE (1) IE45260B1 (enrdf_load_stackoverflow)
LU (1) LU76618A1 (enrdf_load_stackoverflow)
NO (1) NO148542C (enrdf_load_stackoverflow)
SE (1) SE442950B (enrdf_load_stackoverflow)
ZA (1) ZA77327B (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
NZ752946A (en) 2016-12-08 2025-03-28 Scherer Technologies Llc R P A method to relieve stress in capsule shells to reduce propensity to break

Also Published As

Publication number Publication date
ZA77327B (en) 1977-12-28
ES455273A1 (es) 1978-04-01
FI67663C (fi) 1985-05-10
DK27177A (da) 1977-07-24
NO148542B (no) 1983-07-25
FI770070A7 (enrdf_load_stackoverflow) 1977-07-24
IE45260L (en) 1977-07-23
NO770198L (no) 1977-07-26
AU506878B2 (en) 1980-01-24
SE7700665L (sv) 1977-07-24
AU2158977A (en) 1978-08-03
CA1116516A (en) 1982-01-19
FI67663B (fi) 1985-01-31
LU76618A1 (enrdf_load_stackoverflow) 1977-08-12
FR2361104B2 (enrdf_load_stackoverflow) 1982-09-17
NO148542C (no) 1983-11-02
SE442950B (sv) 1986-02-10
FR2361104A2 (fr) 1978-03-10
JPS5294413A (en) 1977-08-09
JPS6228124B2 (enrdf_load_stackoverflow) 1987-06-18

Similar Documents

Publication Publication Date Title
US4161516A (en) Composition for treating airway disease
IE41586B1 (en) Pelletised medicament formulations
EP1007017B2 (en) Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof
JP3011770B2 (ja) 吸入適用のための製剤
CH657273A5 (fr) Compositions pharmaceutiques a inhaler.
CZ289214B6 (cs) Způsob zpracování jemně děleného práąkového léčiva, zařízení k provádění tohoto způsobu a aglomeráty vyrobené tímto způsobem
GB1569611A (en) Pelletised or granular medicament formulation
US6027714A (en) Formulation for inhalation
WO2001026630A1 (fr) Preparations pour inhalation en poudre et leur procede de production
PL189552B1 (pl) Sucha kompozycja proszkowa do inhalacji, sposób jej wytwarzania oraz zastosowania tej kompozycji dowytwarzania leku
JP2005504774A (ja) 吸入可能な粉末の製造方法
WO2003000240A2 (en) Stable powder inhalation dosage formulation
EP1014955B1 (en) New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof
IE45260B1 (en) Pelletised or granular medicament formulation
CA1144862A (en) Composition
US5980949A (en) Formulation for inhalation
JP7575214B2 (ja) 茶加工品及びその製造方法
GB1569612A (en) Disodium cromoglycate pellets or granules
DE2702504A1 (de) Arzneimittel in weicher tabletten- oder koernerform
IE45261B1 (en) Disodium cromoglycate pellets or granules
CA2670153A1 (en) Stable powder formulation containing a novel anticholinergic agent
WO2017146994A1 (en) Controlled agglomeration of micronized drug or drug-excipient mixtures
JPH0142950B2 (enrdf_load_stackoverflow)
JP2003313118A (ja) 造粒物および製造法
TW201221472A (en) Particles carring adsorbent, manufacturing method thereof, tobacco filter and tobacco

Legal Events

Date Code Title Description
MK9A Patent expired